secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRADIMED CORP (IRMD)
CIK:        0001325618
Form:       8-K
Filed at:   2023-08-03T23:59:59+00:00
Accession:  0001558370-23-013067
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IRADIMED reports record Q2 revenue of $16.1M, raises FY2023 guidance
--------------------------------------------------------------------

- Q2 revenue $16.1M (+25% YoY); GAAP diluted EPS $0.33 vs $0.26; non-GAAP EPS $0.36 vs $0.26.
- Operating income $5.0M, up 19% YoY; 8th consecutive record revenue quarter.
- Monitoring devices revenue grew 25% YoY to $6.1M; IV pump systems up 17% to $4.5M.
- FY2023 guidance raised: rev $64.5-$65.5M, GAAP EPS $1.25-$1.28, non-GAAP EPS $1.37-$1.40.
- Q3 2023 guidance: rev $16.1-$16.3M, GAAP EPS $0.33-$0.35, non-GAAP EPS $0.36-$0.38.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1325618/000155837023013067/0001558370-23-013067-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1325618/000155837023013067/irmd-20230803x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-013067

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer